Pfizer buys Wyeth in $68 billion deal

NEW YORK (Reuters) – Pfizer Inc, the No. 1 drugmaker, said on Monday that it would acquire U.S. rival Wyeth for about $68 billion in a move to diversify its revenue base. The world’s largest drugmaker, which raised $22.5 billion in debt from a consortium

Leave a Reply